At Janssen, we are dedicated to addressing and solving some of the most meaningful unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, and cardiovascular and metabolic diseases. Motivated by our dedication to patients, we bring creative products, services and solutions to people throughout the world. Janssen is a pharmaceutical company of Johnson & Johnson. Please visit www.janssen.co.uk for more information.
An exciting new opportunity has arisen for a Commercial Lead - Haematology within Janssen, part of the Johnson and Johnson Family of Companies. Within this position you will be responsible for the following key function:
Ensuring accelerated access & uptake of Janssen’s innovative medicines.
Unlocking local market access barriers.
Co-creating solutions & partnerships with the NHS that deliver value to Janssen, NHS and patients in the Local and national healthcare economy.
Work strategically to understand the local health economy (LHE) and NHS environment to achieve and maintain optimal market access and funding for Janssen medicines and product indications including the pre-license stage when marketing authorisation has not been granted.
Have oversight of the national health economy and TA specific policies that directly impact their local economy and how local strategies may be adopted at national level.
Lead on the development of a differentiated integrated value proposition; shape and implement solutions that improve current patient health outcomes including how our medicines and offerings add value to their patient population and care pathways.
Strategically deliver evidence based value propositions and economic models to appropriate local stakeholders that meet NHS needs for the local health economy, leveraging opportunities in identified areas for improving health outcomes.
Work in collaboration with brand account teams [Regional Business Managers, Account Managers, Medical Science Liaison Manages (MSLs)] to define a local approach demonstrating wider value of products and offerings; develop strategies and solutions that flex around the changing NHS and the specific needs of both customers and patients.
Gather and communicate insights around interdependencies of agencies in NHS environment and apply to the therapy area. Document the insights and present back to the relevant internal stakeholders.
Identify and build relationships with new and emerging stakeholder groups maintaining high standard of NHS knowledge and insights.
Develop and sustain knowledge of policy developments at both national and regional level in the NHS, ensuing insights are disseminated to the wider organisation
Work strategically with relevant external stakeholders to achieve optimal re-reimbursement uptake of Janssen products to improve patient outcomes.
Utilise iConnect to capture and record customer activity and record usage of market access marketing messages and materials.
Have the adaptability to work across different therapy areas to meet business demands
Demonstrate brand leadership (support HEMAR and Commercial partners on the local market access material creation, support the material roll-out and training plans and compliantly upload and remove material on the HELM SharePoint with the support of the Tech-enabler)
Pipeline Products and Product Changes (with no marketing authorisation)
Strategically map and engage with agreed NHS decision makers who have a policy and budgetary role to define market access processes and apply this insight/knowledge to support development of the access strategy for future products and new indications.
Utilise in-depth understanding of current and future NHS policies at a local level, so that the value proposition for new products and services meet the needs of local budgetary and policy stakeholders.
Strategically model the impact of how local strategies may become adopted at a national level and the potential national impact.
Develop data competency to confidently engage with payer stakeholders, assess current outcomes, care pathways and resource allocation to identify future opportunities for service improvement and NHS partnerships.
Build business plans that identify compliant objectives and actions in the pre-license and launch (post marketing authorisation) stages to take full account of and respond to the needs of policy and budget holders across the relevant agencies within the LHE, creating a positive platform for Janssen and its products/services.
At time of launch (when marketing authorisation has been granted), the HELM brand access strategies will be shared with the local brand teams to create joint plans that leverage the value proposition and optimise market access and uptake.
Health Economy Liaison Managers are authorised to undertake Advance Notification for new products and product changes that do not have marketing authorisation in accordance with the requirements of Clause 3.1 ABPI Code of Practice; code training must be completed; all advance notification will be undertaken with a copy approved briefing document.
Utilise iConnect to record customer activity as per SOP; in the pre-licence setting, HELMs must assign the appropriate therapy or product for each call; any customer request for further information on the product and treatments must be forwarded to Medical Information via iConnect Customer Request or by using the hard copy RTCI form.
During an Advance Notification customer call, HELMs must not be accompanied by a member of the sales field based promotional team. Brand Marketing, Medical or Regulatory may attend provided the reason is consistent with Clause 3 ABPI Code of Practice – it is not permitted to proactively promote clinical benefits in the pre-license stage.
The HELMs will develop a general disease knowledge and awareness following a controlled and phased training programme for each new medicine and therapy area they will be working on. Under no circumstances, will the HELMs be trained on detailed medical or scientific information.
Work strategically to understand the business plan (BP) and mid-term plan (MTP) for Janssen products and the translation to the LHE. Pro-actively resolve any anticipated access problems at a local level that may arise from the BP or MTP.
ABPI Code of practice with detailed training on Clause 3.
Working understanding of outcomes research and health economic evaluation processes.
Working understanding of Value Excellence
Knowledge of NHS decision making process and funding flow.
- Health Economy Structure.
- Key Account Working.
Negotiation and influencing skills.
Project management skills.
- Facilitation Skills.
- iConnect Competency.
- Data analytical and technical skills.
We respectfully request Government Officials to identify themselves as such on application; for the purpose of the Foreign Corrupt Practices Act. If you decide to apply for the position, any personal data which you provide shall be processed by Janssen-Cilag Ltd, a Johnson & Johnson company. Your personal data shall be processed for the purposes of recruitment, recruitment policy and selection.
Johnson and Johnson are an equal opportunity employer.
United Kingdom-England-High Wycombe-
Janssen Cilag Ltd. (7360)